Cargando…

Comparison of drug coverage in Canada before and after the establishment of the pan-Canadian Pharmaceutical Alliance

OBJECTIVES: This study was conducted to determine whether establishment of the pan-Canadian Pharmaceutical Alliance (pCPA) was associated with significant changes in drug listing decisions across Canada. ANALYSIS AND RESULTS: This study included drug indications that received a Common Drug Review or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Milliken, Debbie, Venkatesh, Jaya, Yu, Rebecca, Su, Zhuo, Thompson, Melissa, Eurich, Dean
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Health Policy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563252/ https://www.ncbi.nlm.nih.gov/pubmed/26341583 http://dx.doi.org/10.1136/bmjopen-2015-008100

Ejemplares similares

Pan-Canadian Pharmaceutical Alliance (pCPA): Timelines Analysis and Policy Implications
por: Salek, Sam M., et al.
Publicado: (2019)

An analysis of redactions in Canada’s Common Drug Review Clinical Review Reports and how they relate to the patients’ voice
por: Soprovich, Allison, et al.
Publicado: (2017)

Gender and racialisation of pharmaceutical sector leaders in Canada: a cross-sectional study
por: Satgunanathan, Kasthuri, et al.
Publicado: (2023)

Financial conflicts of interest of clinicians making submissions to the pan-Canadian Oncology Drug Review: a descriptive study
por: Lexchin, Joel
Publicado: (2019)

National patient groups in Canada and their disclosure of relationships with pharmaceutical companies: a cross-sectional study
por: Lexchin, Joel, et al.
Publicado: (2022)

Divergent modes of integration: the Canadian way
por: Jiwani, Izzat, et al.
Publicado: (2011)

RELATIONSHIP BETWEEN FINANCIAL IMPACT AND COVERAGE OF DRUGS IN AUSTRALIA
por: Mauskopf, Josephine, et al.
Publicado: (2013)

Rationale, design, and methods for Canadian alliance for healthy hearts and minds cohort study (CAHHM) – a Pan Canadian cohort study
por: Anand, Sonia S., et al.
Publicado: (2016)

Costs of breast cancer care in Mexico: analysis of two insurance coverage scenarios
por: González-Robledo, María Cecilia, et al.
Publicado: (2015)

Ten years of integrated care: backwards and forwards. The case of the province of Québec, Canada
por: Vedel, Isabelle, et al.
Publicado: (2011)

BBMRI-ERIC as a resource for pharmaceutical and life science industries: the development of biobank-based Expert Centres
por: van Ommen, Gert-Jan B, et al.
Publicado: (2015)

Critical Implications of IVDR for Innovation in Diagnostics: Input From the BioMed Alliance Diagnostics Task Force
por: Dombrink, Isabel, et al.
Publicado: (2022)

Keeping an eye on eye care: monitoring progress towards effective coverage
por: Keel, Stuart, et al.
Publicado: (2021)

Soft Targets: Nurses and the Pharmaceutical Industry
por: Jutel, Annemarie, et al.
Publicado: (2008)

Dataset on cost-analysis of medication deprescribing scenarios for older adult coverage under public drug benefit programs in Canada
por: Fadaleh, Sarah Abu, et al.
Publicado: (2020)

Progress toward integrating care for seniors in Canada: “We have to skate toward where the puck is going to be, not to where it has been.”
por: MacAdam, Margaret
Publicado: (2011)

An equity dashboard to monitor vaccination coverage
por: Arsenault, Catherine, et al.
Publicado: (2017)

Increasing transparency and accountability in national pharmaceutical systems
por: Paschke, Anne, et al.
Publicado: (2018)

Perspectives on the establishment of a canadian human taphonomic facility: The experience of REST[ES]
por: Pecsi, Emily L., et al.
Publicado: (2020)

Is Indonesia achieving universal health coverage? Secondary analysis of national data on insurance coverage, health spending and service availability
por: Pratiwi, Agnes Bhakti, et al.
Publicado: (2021)

Implications of dual practice for universal health coverage
por: McPake, Barbara, et al.
Publicado: (2016)

Priority-setting for achieving universal health coverage
por: Chalkidou, Kalipso, et al.
Publicado: (2016)

Universal health coverage and primary care, Thailand
por: Sumriddetchkajorn, Kanitsorn, et al.
Publicado: (2019)

Developing the health workforce for universal health coverage
por: Cometto, Giorgio, et al.
Publicado: (2020)

Tailored HIV programmes and universal health coverage
por: Holmes, Charles B, et al.
Publicado: (2020)

Disclosure of payments by pharmaceutical companies to healthcare professionals in the UK: analysis of the Association of the British Pharmaceutical Industry’s Disclosure UK database, 2015 and 2016 cohorts
por: Mulinari, Shai, et al.
Publicado: (2018)

Communities, universal health coverage and primary health care
por: Sacks, Emma, et al.
Publicado: (2020)

Legal and institutional foundations for universal health coverage, Kenya
por: Mbindyo, Regina, et al.
Publicado: (2020)

Legislating for public accountability in universal health coverage, Thailand
por: Kantamaturapoj, Kanang, et al.
Publicado: (2020)

Mandatory Disclosure of Pharmaceutical Industry-Funded Events for Health Professionals
por: Robertson, Jane, et al.
Publicado: (2009)

The Canadian Natural Health Products (NHP) Regulations: Industry Compliance Motivations
por: Laeeque, Hina, et al.
Publicado: (2007)

Challenges facing the United States of America in implementing universal coverage
por: Rice, Thomas, et al.
Publicado: (2014)

Building from the HIV Response toward Universal Health Coverage
por: Jay, Jonathan, et al.
Publicado: (2016)

Pooling financial resources for universal health coverage: options for reform
por: Mathauer, Inke, et al.
Publicado: (2020)

Primary health care contributions to universal health coverage, Ethiopia
por: Assefa, Yibeltal, et al.
Publicado: (2020)

Strengthening family medicine: a Canadian perspective and the RCGP International and Overseas Network
por: Agarwal, Gina
Publicado: (2017)

The Canadian Alliance for Healthy Hearts and Minds: How Well Does It Reflect the Canadian Population?
por: Hall, Ruth E., et al.
Publicado: (2020)

Other considerations than: how much will universal health coverage cost?
por: Barber, Sarah L, et al.
Publicado: (2020)

Reforms for financial protection schemes towards universal health coverage, Senegal
por: Daff, Bocar Mamadou, et al.
Publicado: (2020)

Evolution of Government-funded health insurance for universal health coverage in India
por: Dubey, Sweta, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kke9j8ua21d7nhso4672siinmg